UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

Molecular cancer research, 2018-05, Vol.16 (5), p.805-812

2018

Volltextzugriff (PDF)

A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer

Cancer, 2018-06, Vol.124 (11), p.2337-2346

2018

Volltextzugriff (PDF)

Landscape of KRAS G12C , Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS -Mutated Cancers

JCO precision oncology, 2022-05, Vol.6, p.e2100245

2022

Volltextzugriff (PDF)

Maintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy: a retrospective cohort study

Gastrointestinal cancer research, 2014-05, Vol.7 (3-4), p.91-97

2014

Volltextzugriff (PDF)

Irinotecan and 5-FU/ leucovorin in metastatic colorectal cancer: balancing efficacy, toxicity, and logistics

Oncology (Williston Park, N.Y.), 2004-12, Vol.18 (14 Suppl 14), p.26

Hwang, Jimmy J

2004

Volltextzugriff (PDF)

Phase II study of fluorouracil (FU), leucovorin (LV), and nanoliposomal irinotecan (nal-IRI) in previously treated advanced biliary tract cancer (NAPOLI-2)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.TPS593-TPS593

2020

Volltextzugriff (PDF)

A phase I, open-label, dose-escalation trial of BI 1701963 as monotherapy and in combination with trametinib in patients with KRAS mutated advanced or metastatic solid tumors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS3651-TPS3651

2020

Volltextzugriff (PDF)

Low Overexpression of HER-2 Neu in Advanced Colorectal Cancer Limits the Usefulness of Trastuzumab (Herceptin®) and Irinotecan as Therapy. A Phase II Trial

Cancer investigation, 2004, Vol.22 (6), p.858-865

2004

Volltextzugriff (PDF)

Enrichment of alterations in targetable molecular pathways in KRAS wild-type (WT) pancreatic cancer (PC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4629-4629

2020

Volltextzugriff (PDF)

Nintedanib in metastatic appendiceal carcinoma

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.TPS723-TPS723

2019

Volltextzugriff (PDF)

The landscape of MAP3K1 / MAP2K4 alterations in gastrointestinal (GI) malignancies

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4113-4113

2020

Volltextzugriff (PDF)

Characterization of sociodemographic and clinicopathological features and associated outcomes of patients (Pts) with anal squamous cell cancer (ASCC): Analysis of 44,084 pts in the National Cancer Database (NCDB)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4052-4052

2020

Volltextzugriff (PDF)

Improving the toxicity of irinotecan/5-FU/leucovorin: a 21-day schedule

Oncology (Williston Park, N.Y.), 2003-09, Vol.17 (9 Suppl 8), p.37

2003

Volltextzugriff (PDF)

Molecular characterization of appendiceal goblet cell carcinoid

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.231-231

2020

Volltextzugriff (PDF)

Sociodemographic disparities in young adults with colorectal cancer (CRC): Analysis of 26,768 patients in the National Cancer Database (NCDB)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.13-13

2020

Volltextzugriff (PDF)

An institutional series of early-onset pancreatic cancer (EOPC): Clinical outcomes and genetic and supportive care referral patterns

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.652-652

2020

Volltextzugriff (PDF)

Change of clinical features and outcomes of adolescents and young adults (AYA) with colorectal cancer over time: Pooled analysis of 26,768 patients in the National Cancer Database (NCDB)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.256-256

2020

Volltextzugriff (PDF)

Combined inhibition of topoisomerases: a phase I. Study of irinotecan and epirubicin

Oncology (Williston Park, N.Y.), 2003-05, Vol.17 (5 Suppl 5), p.46

2003

Volltextzugriff (PDF)

Colorectal cancer: Impact of primary tumor location on genetic alterations

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3578-3578

2017

Volltextzugriff (PDF)

Final report of a phase I/II study of veliparib (Vel) in combination with 5-FU and oxaliplatin (FOLFOX) in patients (pts) with metastatic pancreatic cancer (mPDAC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4015-4015

2019

Volltextzugriff (PDF)

Capecitabine: fulfilling the promise of oral chemotherapy

Expert opinion on pharmacotherapy, 2002-06, Vol.3 (6), p.733-743

2002

Volltextzugriff (PDF)

Locally advanced esophageal carcinoma: at the crossroads of evidence-based medicine and patient care

Clinical advances in hematology & oncology, 2003-05, Vol.1 (5), p.289

Hwang, Jimmy J

2003

Volltextzugriff (PDF)

Association of DNA damage response and repair genes (DDR) mutations and microsatellite instability (MSI), PD-L1 expression, tumor mutational burden (TMB) in gastroesophageal cancers

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.60-60

2019

Volltextzugriff (PDF)

Gene-specific features (MLH1, MSH2, MSH6, PMS2) of mismatch repair (MMR) protein expression and somatic mutations (muts), microsatellite instability (MSI) and tumor mutational burden (TMB) in MSI-H and MMR-mutated tumor genomic profiles (TGPs)

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.505-505

2019

Volltextzugriff (PDF)

Somatic alterations of NF1 in colorectal cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4066-4066

2020

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Englisch
(94)
Japanisch
(3)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Journal Of Clinical Oncology
(60)
Cancer Research
(9)
Cancer
(3)
Oncology
(3)
Journal Of Applied Social Psychology
(2)
Archives Of Sexual Behavior
(1)
Bjc Reports
(1)
Blood
(1)
Breast Cancer Research And Treatment
(1)
Cancer Investigation
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer

Landscape of KRAS G12C , Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS -Mutated Cancers

Maintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy: a retrospective cohort study

Irinotecan and 5-FU/ leucovorin in metastatic colorectal cancer: balancing efficacy, toxicity, and logistics

Phase II study of fluorouracil (FU), leucovorin (LV), and nanoliposomal irinotecan (nal-IRI) in previously treated advanced biliary tract cancer (NAPOLI-2)

A phase I, open-label, dose-escalation trial of BI 1701963 as monotherapy and in combination with trametinib in patients with KRAS mutated advanced or metastatic solid tumors

Low Overexpression of HER-2 Neu in Advanced Colorectal Cancer Limits the Usefulness of Trastuzumab (Herceptin®) and Irinotecan as Therapy. A Phase II Trial

Enrichment of alterations in targetable molecular pathways in KRAS wild-type (WT) pancreatic cancer (PC)

Nintedanib in metastatic appendiceal carcinoma

The landscape of MAP3K1 / MAP2K4 alterations in gastrointestinal (GI) malignancies

Characterization of sociodemographic and clinicopathological features and associated outcomes of patients (Pts) with anal squamous cell cancer (ASCC): Analysis of 44,084 pts in the National Cancer Database (NCDB)

Improving the toxicity of irinotecan/5-FU/leucovorin: a 21-day schedule

Molecular characterization of appendiceal goblet cell carcinoid

Sociodemographic disparities in young adults with colorectal cancer (CRC): Analysis of 26,768 patients in the National Cancer Database (NCDB)

An institutional series of early-onset pancreatic cancer (EOPC): Clinical outcomes and genetic and supportive care referral patterns

Change of clinical features and outcomes of adolescents and young adults (AYA) with colorectal cancer over time: Pooled analysis of 26,768 patients in the National Cancer Database (NCDB)

Combined inhibition of topoisomerases: a phase I. Study of irinotecan and epirubicin

Colorectal cancer: Impact of primary tumor location on genetic alterations

Final report of a phase I/II study of veliparib (Vel) in combination with 5-FU and oxaliplatin (FOLFOX) in patients (pts) with metastatic pancreatic cancer (mPDAC)

Capecitabine: fulfilling the promise of oral chemotherapy

Locally advanced esophageal carcinoma: at the crossroads of evidence-based medicine and patient care

Association of DNA damage response and repair genes (DDR) mutations and microsatellite instability (MSI), PD-L1 expression, tumor mutational burden (TMB) in gastroesophageal cancers

Gene-specific features (MLH1, MSH2, MSH6, PMS2) of mismatch repair (MMR) protein expression and somatic mutations (muts), microsatellite instability (MSI) and tumor mutational burden (TMB) in MSI-H and MMR-mutated tumor genomic profiles (TGPs)

Somatic alterations of NF1 in colorectal cancer

Aktive Filter

Suchergebnisse filtern